Skip to content
Search

Latest Stories

'Long Covid may affect multiple parts of body, mind'

Ongoing illness after infection with Covid-19, sometimes called 'long Covoid', may not be one syndrome but possibly up to four causing a rollercoaster of symptoms affecting all parts of the body and mind, doctors said on Thursday (Oct 15).

In an initial report about long-term Covid-19, Britain’s National Institute for Health Research (NIHR) said one common theme among ongoing Covid patients - some of whom are seven months or more into their illness - is that symptoms appear in one physiological area, such as the heart or lungs, only to abate and then arise again in a different area.


“This review highlights the detrimental physical and psychological impact that ongoing Covid is having on many people’s lives,” said Dr Elaine Maxwell, who led the report.

Many thousands of people worldwide have linked up on social media platforms and online forums to share their experiences of ongoing Covid-19 symptoms. Some call themselves 'long haulers' while others have named their condition 'long Covid'.

According to UK-based patient group LongCovidSOS, data from a King’s College London-devised symptom tracker app shows that 10 per cent of Covid-19 patients remain unwell after three weeks, and up to 5 per cent may continue to be sick for months.

Maxwell, who presented the findings of the 'Living with Covid' report in an online media briefing, said health services are already struggling “to manage these new and fluctuating patterns of symptoms and problems”.

She and her co-authors urged patients and doctors to log and track symptoms so that health researchers can learn more about the condition and how to ease it as swiftly as possible.

“Despite the uncertainties, people need help now,” she said. “We need to collect more data.”

For this initial report, Maxwell’s team held a focus group with 14 members of a Facebook group called Long Covid.

Their testimony suggested ongoing Covid can be cyclical, Maxwell said, with symptoms fluctuating in severity and moving around the body including around the respiratory system, the brain, cardiovascular system and heart, the kidneys, the gut, the liver and the skin.

“There are powerful stories that ongoing Covid symptoms are experienced by people of all ages, and people from all backgrounds,” the report said.

Maxwell said an urgent priority is to establish a working diagnosis recognised by healthcare services, employers and government agencies to help patients get support.

“While this is a new disease and we are learning more about its impact..., services will need to be better equipped to support people with ongoing Covid, as emerging evidence is showing there are significant psychological and social impacts that will have long term consequences,” the report said.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less